Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neoplasm Metastasis × Busulfan × Clear all

Phase

Status

Sponsor Class

OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 126 Myelodysplastic Syndromes 99 Leukemia 98 Precursor Cell Lymphoblastic Leukemia-Lymphoma 82 Lymphoma 77 Lymphoma, Non-Hodgkin 71 Multiple Myeloma 63 Hodgkin Disease 58 Leukemia, Lymphocytic, Chronic, B-Cell 51 Lymphoma, Large B-Cell, Diffuse 43 Myeloproliferative Disorders 42 Leukemia, Myeloid, Accelerated Phase 41 Leukemia, Myeloid, Chronic-Phase 40 Neoplasms, Plasma Cell 39 Leukemia, Myelomonocytic, Chronic 39 Congenital Abnormalities 39 Lymphoma, Follicular 38 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 36 Lymphoma, Mantle-Cell 35 Burkitt Lymphoma 35 Blast Crisis 34 Lymphoma, B-Cell, Marginal Zone 33 Lymphoma, Large-Cell, Immunoblastic 32 Recurrence 30 Primary Myelofibrosis 29 Hematologic Neoplasms 29 Myelodysplastic-Myeloproliferative Diseases 28 Anemia, Refractory, with Excess of Blasts 27 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 26 Graft vs Host Disease 26

Interventions

Radiosurgery 74 Capecitabine 70 Oxaliplatin 63 Bevacizumab 62 Fluorouracil 61 Gemcitabine 56 Leucovorin 55 Nivolumab 49 pembrolizumab 46 Paclitaxel 41 Irinotecan 41 Radiotherapy 38 Cisplatin 35 Magnetic Resonance Spectroscopy 33 Everolimus 31 Cyclophosphamide 31 Cetuximab 31 Drug Therapy 30 Docetaxel 29 Ipilimumab 28 Carboplatin 27 Trastuzumab 25 Sorafenib 24 Sunitinib 23 Erlotinib Hydrochloride 20 Surveys and Questionnaires 19 Specimen Handling 18 Doxorubicin 18 Biopsy 18 Surgical Procedures, Operative 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00987636 2019-10-22

EWING2008

University Hospital Muenster

Phase 3 Completed

Neoplasm Metastasis, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡